Short report
BMC Medical Research Methodology 2016 16(Suppl 1):74
Published on: 8 July 2016
Volume 16 Supplement 1
Data sharing in pharma
Research
Publication of this supplement was supported by Amgen, Bayer Pharms AG and Hoffman La Roche. Articles have undergone the journal's standard peer review process for supplements. The Supplement Editor declares that they have no competing interests.
Edited by Philip Debruyne.
-
-
Correspondence article
Protecting patient privacy when sharing patient-level data from clinical trials
Greater transparency and, in particular, sharing of patient-level data for further scientific research is an increasingly important topic for the pharmaceutical industry and other organisations who sponsor and...
BMC Medical Research Methodology 2016 16(Suppl 1):77
Published on: 8 July 2016
-
Correspondence article
Best practice for analysis of shared clinical trial data
Greater transparency, including sharing of patient-level data for further research, is an increasingly important topic for organisations who sponsor, fund and conduct clinical trials. This is a major paradigm ...
BMC Medical Research Methodology 2016 16(Suppl 1):76
Published on: 8 July 2016
-
Correspondence article
EFSPI/PSI working group on data sharing: accessing and working with pharmaceutical clinical trial patient level datasets – a primer for academic researchers
Access to patient level datasets from clinical trial sponsors continues to be an important topic for the Pharmaceutical Industry as well as academic institutions and researchers. How to make access to patient ...
BMC Medical Research Methodology 2016 16(Suppl 1):73
Published on: 8 July 2016
-
Correspondence article
Data sharing and the evolving role of statisticians
Greater transparency and, in particular, sharing of clinical study reports and patient level data for further research is an increasingly important topic for the pharmaceutical and biotechnology industry and o...
BMC Medical Research Methodology 2016 16(Suppl 1):75
Published on: 8 July 2016
